AEye Reports First Quarter 2024 Results
Kicked off key strategic partnership that will bring AEye’s lidar into the
Fourth consecutive quarter of cash burn reduction
Management Commentary
“AEye made incredible progress with our capital-light partnership model in the first quarter, including significantly expanding our strategic opportunities and opening the door to the booming lidar market in
Key Q1 2024 Financial Highlights
“We remain focused on cost discipline and have reduced our cash burn rate for the fourth consecutive quarter. With
In
-
GAAP net loss was
$(10.2) million , or$(1.61) per share, based on 6.4 million weighted average common shares outstanding. -
Non-GAAP net loss was
$(7.2) million , or$(1.13) per share, based on 6.4 million weighted average common shares outstanding. -
Cash, cash equivalents, and marketable securities were
$28.9 million as ofMarch 31, 2024 .
Conference Call and Webcast Details
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
Access is also available via:
Conference call: https://aeye.pub/3W7rZlg
Webcast: https://aeye.pub/3Uq2JW4
About
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance.
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in
This press release includes non-GAAP financial measures, including:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, less change in fair value of convertible note and warrant liabilities, plus one-time termination benefits and other restructuring costs; and
- Adjusted EBITDA, defined as non-GAAP net loss plus depreciation and amortization expense, less interest expense and other, less interest income and other, plus provision for income tax expense.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about
Readers are cautioned not to put undue reliance on forward-looking statements;
|
||||||
ASSETS | ||||||
Current Assets: | ||||||
Cash and cash equivalents | $ |
9,535 |
|
$ |
16,932 |
|
Marketable securities |
19,374 |
|
19,591 |
|
||
Accounts receivable, net |
67 |
|
131 |
|
||
Inventories, net |
557 |
|
583 |
|
||
Prepaid and other current assets |
1,745 |
|
2,517 |
|
||
Total current assets |
31,278 |
|
39,754 |
|
||
Right-of-use assets |
10,862 |
|
11,226 |
|
||
Property and equipment, net |
339 |
|
281 |
|
||
Restricted cash |
2,150 |
|
2,150 |
|
||
Other noncurrent assets |
798 |
|
906 |
|
||
Total assets | $ |
45,427 |
|
$ |
54,317 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
Current Liabilities: | ||||||
Accounts payable | $ |
3,751 |
|
$ |
3,442 |
|
Accrued expenses and other current liabilities |
5,239 |
|
6,585 |
|
||
Total current liabilities |
8,990 |
|
10,027 |
|
||
Operating lease liabilities, noncurrent |
14,464 |
|
14,858 |
|
||
Other noncurrent liabilities |
49 |
|
409 |
|
||
Total liabilities |
23,503 |
|
25,294 |
|
||
Stockholders' Equity: | ||||||
Preferred stock |
— |
|
— |
|
||
Common stock |
1 |
|
1 |
|
||
Additional paid-in capital |
369,781 |
|
366,647 |
|
||
Accumulated other comprehensive (loss) income |
(4 |
) |
10 |
|
||
Accumulated deficit |
(347,854 |
) |
(337,635 |
) |
||
Total stockholders’ equity |
21,924 |
|
29,023 |
|
||
Total liabilities and stockholders’ equity | $ |
45,427 |
|
$ |
54,317 |
|
|
||||||
Three months ended |
||||||
2024 |
|
2023 |
|
|||
Revenue: | ||||||
Prototype sales | $ |
20 |
|
$ |
125 |
|
Development contracts |
— |
|
511 |
|
||
Total revenue |
20 |
|
636 |
|
||
Cost of revenue |
263 |
|
2,261 |
|
||
Gross loss |
(243 |
) |
(1,625 |
) |
||
Operating expenses: | ||||||
Research and development |
4,532 |
|
9,442 |
|
||
Sales and marketing |
341 |
|
6,268 |
|
||
General and administrative |
5,615 |
|
8,554 |
|
||
Total operating expenses |
10,488 |
|
24,264 |
|
||
Loss from operations |
(10,731 |
) |
(25,889 |
) |
||
Other income (expense): | ||||||
Change in fair value of convertible note and warrant liabilities |
2 |
|
(810 |
) |
||
Interest income and other |
195 |
|
277 |
|
||
Interest expense and other |
317 |
|
176 |
|
||
Total other income (expense), net |
514 |
|
(357 |
) |
||
Loss before income tax expense |
(10,217 |
) |
(26,246 |
) |
||
Provision for income tax expense |
2 |
|
19 |
|
||
Net loss | $ |
(10,219 |
) |
$ |
(26,265 |
) |
Per Share Data | ||||||
Net loss per common share (basic and diluted) | $ |
(1.61 |
) |
$ |
(4.75 |
) |
Weighted average common shares outstanding (basic and diluted) |
6,352,835 |
|
5,528,862 |
|
||
|
||||||
Three months ended |
||||||
2024 |
|
2023 |
|
|||
Cash flows from operating activities: | ||||||
Net loss | $ |
(10,219 |
) |
$ |
(26,265 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization |
29 |
|
330 |
|
||
Gain on sale of property and equipment, net |
— |
|
(53 |
) |
||
Noncash lease expense relating to operating lease right-of-use assets |
364 |
|
350 |
|
||
Inventory write-downs, net of scrapped inventory |
19 |
|
208 |
|
||
Change in fair value of convertible note and warrant liabilities |
(2 |
) |
810 |
|
||
Stock-based compensation |
3,014 |
|
6,513 |
|
||
Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest |
(252 |
) |
33 |
|
||
Expected credit losses |
14 |
|
— |
|
||
Changes in operating assets and liabilities: | ||||||
Accounts receivable, net |
50 |
|
494 |
|
||
Inventories, current and noncurrent, net |
18 |
|
(386 |
) |
||
Prepaid and other current assets |
772 |
|
2,722 |
|
||
Other noncurrent assets |
97 |
|
71 |
|
||
Accounts payable |
309 |
|
(985 |
) |
||
Accrued expenses and other current liabilities |
(1,343 |
) |
(134 |
) |
||
Operating lease liabilities |
(397 |
) |
(392 |
) |
||
Other noncurrent liabilities |
(358 |
) |
— |
|
||
Contract liabilities |
— |
|
(511 |
) |
||
Net cash used in operating activities |
(7,885 |
) |
(17,195 |
) |
||
Cash flows from investing activities: | ||||||
Purchases of property and equipment |
(87 |
) |
(599 |
) |
||
Proceeds from sale of property and equipment |
— |
|
76 |
|
||
Purchases of marketable securities |
(6,045 |
) |
— |
|
||
Proceeds from redemptions and maturities of marketable securities |
6,500 |
|
22,000 |
|
||
Net cash provided by investing activities |
368 |
|
21,477 |
|
||
Cash flows from financing activities: | ||||||
Proceeds from exercise of stock options |
— |
|
323 |
|
||
Payments for convertible note redemptions |
— |
|
(2,300 |
) |
||
Taxes paid related to the net share settlement of equity awards |
(45 |
) |
(868 |
) |
||
Proceeds from issuance of common stock under the Common Stock Purchase Agreement |
165 |
|
— |
|
||
Net cash provided by (used in) financing activities |
120 |
|
(2,845 |
) |
||
Net (decrease) increase in cash, cash equivalents and restricted cash |
(7,397 |
) |
1,437 |
|
||
Cash, cash equivalents and restricted cash at beginning of period |
19,082 |
|
21,214 |
|
||
Cash, cash equivalents and restricted cash at end of period | $ |
11,685 |
|
$ |
22,651 |
|
|
||||||
Three months ended |
||||||
2024 |
|
2023 |
|
|||
GAAP net loss | $ |
(10,219 |
) |
$ |
(26,265 |
) |
Non-GAAP adjustments: | ||||||
Stock-based compensation |
3,014 |
|
6,513 |
|
||
Change in fair value of convertible note and warrant liabilities |
(2 |
) |
810 |
|
||
One-time termination benefits and other restructuring costs |
— |
|
1,253 |
|
||
Non-GAAP net loss | $ |
(7,207 |
) |
$ |
(17,689 |
) |
Depreciation and amortization expense |
29 |
|
330 |
|
||
Interest income and other |
(195 |
) |
(277 |
) |
||
Interest expense and other |
(317 |
) |
(176 |
) |
||
Provision for income tax expense |
2 |
|
19 |
|
||
Adjusted EBITDA | $ |
(7,688 |
) |
$ |
(17,793 |
) |
GAAP net loss per share attributable to common stockholders: | ||||||
Basic and diluted | $ |
(1.61 |
) |
$ |
(4.75 |
) |
Non-GAAP net loss per share attributable to common stockholders: | ||||||
Basic and diluted | $ |
(1.13 |
) |
$ |
(3.20 |
) |
Shares used in computing GAAP net loss per share attributable to common stockholders: | ||||||
Basic and diluted |
6,352,835 |
|
5,528,862 |
|
||
Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | ||||||
Basic and diluted |
6,352,835 |
|
5,528,862 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514436358/en/
Lbannister@aeye.ai
925-400-4366
eniu@finprofiles.com
310-622-8243
Source: